Sarissa Capital Management LP's Net Worth
$0
Estimate Recalculated Sep 18, 2024 03:06PM EST
Who is Sarissa Capital Management LP?
Sarissa Capital Management LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include APRICUS BIOSCIENCES, INC., VIVUS INC, IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., Iterum Therapeutics plc, Regulus Therapeutics Inc., and Innoviva, Inc..
SEC CIK
Sarissa Capital Management LP's CIK is 0001577524
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $4.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.21% | 3.28K |
—
|
—
| 152.1K |
Sep 16
| |||
Form 4
| +19.53% | 24.31K |
—
|
—
| 148.82K |
Jun 18
| |||
Form 4
| +2.11% | 2.57K |
—
|
—
| 124.51K |
Jun 15
| |||
Form 4
| +1.38% | 1.66K |
—
|
—
| 121.94K |
Mar 15
| |||
Form 4
| +1.13% | 1.35K |
—
|
—
| 120.28K |
Dec 15
| |||
Form 4
| +1.54% | 1.8K |
—
|
—
| 118.93K |
Sep 15
| |||
Form 4
| +23.58% | 22.35K |
—
|
—
| 117.13K |
Jun 20
| |||
Form 4
| +1.45% | 1.36K |
—
|
—
| 94.78K |
Jun 15
| |||
Form 4
| +1.56% | 1.44K |
—
|
—
| 93.42K |
Mar 15
| |||
Form 4
| +1.37% | 1.24K |
—
|
—
| 91.98K |
Dec 15
| |||
Form 4
| +1.54% | 1.37K |
—
|
—
| 90.74K |
Sep 15
| |||
Form 4
| +1.39% | 1.22K |
—
|
—
| 89.37K |
Jun 15
| |||
Form 4
| +32.40% | 21.57K |
—
|
—
| 88.14K |
Jun 1
| |||
Form 4
| +1.76% | 1.15K |
—
|
—
| 66.57K |
Mar 15
| |||
Form 4
| +1.89% | 1.21K |
—
|
—
| 65.42K |
Dec 15
| |||
Form 4
| +1.80% | 1.14K |
—
|
—
| 64.21K |
Sep 15
| |||
Form 4
| +1.99% | 1.23K |
—
|
—
| 63.07K |
Jun 15
| |||
Form 4
| +58.26% | 22.77K |
—
|
—
| 61.84K |
Jun 2
| |||
Form 4
| +3.26% | 1.24K |
—
|
—
| 39.08K |
Mar 15
| |||
Form 4
| +1.39% | 225K |
$10.38 | $2,335,500.00 | 16.39M |
Mar 8 - Mar 10
| |||
Form 4
| +5.04% | 775K |
$10.01 | $7,758,750.00 | 16.16M |
Mar 3 - Mar 5
| |||
| No matching records found | |||||||||
Sarissa Capital Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.43 | -$50,007,284.23 | 20.62M |
Feb 11 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.2305
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +0.42% | 6.1K |
$1.63 | $9,949.52 | 1.45M |
Aug 31
| |||
Form 4
| +84.89% | 6.65M |
$0.88 | $5,850,000.64 | 14.48M |
Mar 3
| |||
Form 4
| +20.03% | 1.31M |
$0.88 | $1,150,000.72 | 7.83M |
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||